Randomized Trial Comparing Colesevelam vs. Ezetimibe
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.
Also called NCT02682680
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 200 participants
- Registry
-
NCT02682680
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Canada
- Registry status
- Completed
Technical summary
Registry record NCT02682680. Randomized; no masking; primary purpose treatment. Start 2016-01-11 (actual); primary completion 2017-05-25 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Randomized Trial Comparing Colesevelam vs. Ezetimibe
- Acronym
- GOAL-RCT
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- Colesevelam
- Intervention (Drug)
- Ezetimibe
- Lead sponsor
- LMC Diabetes & Endocrinology Ltd.
- Collaborator
- Bausch Health Americas, Inc.
Record details
- Record id
cardio:ct-nct02682680- Content hash
3310211e0bea86f9a2b8c1b75f477b176ec6b236c9039289b6e1d3fa5246b297